Andreas Kirsch

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 898 citations

Medicine, Oncology, Pharmacology +14

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 159 citations · Full text

Medicine, Immunology, Oncology +13

Characterization and Measurement of CD34-Expressing Hematopoietic Cells

Carla Kreissig, Andreas Kirsch, Stefan Serke · Journal of Hematotherapy · 1994 · 49 citations

Life Sciences, Cell Biology, Hematology +17

Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood

Tino F. Schwarz, Stefan Serke, Barbara Hottenträger et al. · Journal of Virology · 1992 · 43 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Productive infection of <i>in vitro</i> generated haemopoietic progenitor cells from normal human adult peripheral blood with parvovirus B19: studies by morphology, immunocytochemistry, flow‐cytometry and DNA‐hybridization

Stefan Serke, Tino F. Schwarz, H. Baurmann et al. · British Journal of Haematology · 1991 · 36 citations

Life Sciences, Hematology, Microbiology +13